Ian Ganly

Active 1995–2025

182
Papers
26,781
Citations
89
h-index
170
i10-index

Citations

Citations per year for Ian Ganly1928: 1 citations1984: 1 citations1992: 1 citations1995: 1 citations2000: 20 citations2001: 73 citations2002: 79 citations2003: 96 citations2004: 54 citations2005: 42 citations2006: 37 citations2007: 34 citations2008: 41 citations2009: 35 citations2010: 32 citations2011: 35 citations2012: 64 citations2013: 80 citations2014: 116 citations2015: 155 citations2016: 217 citations2017: 286 citations2018: 228 citations2019: 1,023 citations2020: 1,220 citations2021: 1,110 citations2022: 934 citations2023: 700 citations2024: 1,120 citations2025: 475 citations2026: 13 citations1929–1983: no citations, so these years are not shown1985–1991: no citations, so these years are not shown1993–1994: no citations, so these years are not shown1996–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,680 citing papers, 27.2% of this breakdownChina: 1,266 citing papers, 12.9% of this breakdownItaly: 617 citing papers, 6.3% of this breakdownUnited Kingdom: 460 citing papers, 4.7% of this breakdownGermany: 405 citing papers, 4.1% of this breakdownCanada: 342 citing papers, 3.5% of this breakdownFrance: 307 citing papers, 3.1% of this breakdownJapan: 299 citing papers, 3% of this breakdownSouth Korea: 293 citing papers, 3% of this breakdownNetherlands: 244 citing papers, 2.5% of this breakdownSpain: 238 citing papers, 2.4% of this breakdownAustralia: 203 citing papers, 2.1% of this breakdown
0%27.2%Other 25.2%

Fields

  • Medicine70%
  • Biochemistry, Genetics and Molecular Biology21.5%
  • Immunology and Microbiology2.9%
  • Dentistry2.7%
  • Computer Science0.6%
  • Engineering0.6%
  • Other1.7%

Topics

  • Thyroid Cancer Diagnosis and Treatment10%
  • Head and Neck Cancer Studies6%
  • Thyroid and Parathyroid Surgery3.8%
  • Cancer Immunotherapy and Biomarkers3.5%
  • Salivary Gland Tumors Diagnosis and Treatment2.6%
  • Thyroid Disorders and Treatments2.6%
  • Other71.5%

Coauthors

All papers

Open in search
  1. Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy A. Chan, Amy Y. Chen, Andrew D. Cherniack, Dorothy Cheung, Lynda Chin, Juok Cho, Andy Chu, Eric Chuah, Kristian Cibulskis, Giovanni Ciriello, Amanda Clarke, Gary L. Clayman, Leslie Cope, John A. Copland, Kyle R. Covington, Ludmila Danilova, Tanja M. Davidsen, John A. Demchok, Daniel DiCara, Noreen Dhalla, Rajiv Dhir, Sheliann S. Dookran, Gideon Dresdner, Jonathan Eldridge, Greg Eley, Adel K. El‐Naggar, Stephanie Eng, James A. Fagin, Timothy R. Fennell, Robert L. Ferris, Sheila Fisher, Scott Frazer, Jessica Frick, Stacey Gabriel, Ian Ganly, Jianjiong Gao, Levi A. Garraway, Julie M. Gastier-Foster, Gad Getz, Nils Gehlenborg, Ronald Ghossein, Richard A. Gibbs, Thomas J. Giordano, Karen Gomez-Hernandez, Jonna Grimsby, Benjamin Groß, Ranabir Guin, Angela Hadjipanayis, Hollie A. Harper, D. Neil Hayes, David I. Heiman, James G. Herman, Katherine A. Hoadley, Matan Hofree, Robert A. Holt, Alan P. Hoyle, Franklin W. Huang, Mei Huang, Carolyn M. Hutter, Trey Ideker, Lisa Iype, Anders Jacobsen, Stuart R. Jefferys, Corbin D. Jones, Steven J.M. Jones, Katayoon Kasaian, Electron Kebebew, Fadlo R. Khuri, Jaegil Kim, Roger Kramer and 143 more - Cell 2014 cited by 3,126

  2. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 1,284

  3. Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 456

  4. The head and neck cancer immune landscape and its immunotherapeutic implications

    Authors: , , , , , , , , , , - JCI Insight 2016 cited by 790

  5. Immunogenic neoantigens derived from gene fusions stimulate T cell responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard J. Wong, Neerav Shukla, Timothy A. Chan, Luc G.T. Morris - Nature Medicine 2019 cited by 382

  6. Survival outcomes after treatment of cancer of the oral cavity (1985–2015)

    Authors: , , , , , , - Oral Oncology 2019 cited by 514

  7. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer

    Authors: , , , , , , , , , , , , - JAMA Oncology 2018 cited by 331

  8. Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects

    Authors: , , , - Thyroid 2019 cited by 249

  9. The association between tumor mutational burden and prognosis is dependent on treatment context

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2021 cited by 260

  10. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus

    Authors: , , , , , , , , , , , , , - International Journal of Cancer 2019 cited by 185

  11. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Otolaryngology–Head & Neck Surgery 2017 cited by 479

  12. Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2018 cited by 284

  13. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 210

  14. Primary high‐grade non‐anaplastic thyroid carcinoma: a retrospective study of 364 cases

    Authors: , , , , , , , , , , , , - Histopathology 2021 cited by 105

  15. Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Fetten, Anuja Kripani, David G. Pfister, Alan L. Ho, Amita Shukla‐Dave, John L. Humm, Simon N. Powell, Bob T. Li, Jorge S. Reis‐Filho, Luis A. Díaz, Richard J. Wong, Nadeem Riaz - Journal of Clinical Oncology 2024 cited by 93

  16. Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

    Authors: , , , , , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2022 cited by 57

  17. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 137

  18. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 363

  19. A Proposal to Redefine Close Surgical Margins in Squamous Cell Carcinoma of the Oral Tongue

    Authors: , , , , , , , , , - JAMA Otolaryngology–Head & Neck Surgery 2017 cited by 161

  20. Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease

    Authors: , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2013 cited by 463

  21. DNA methylation-based classification of sinonasal undifferentiated carcinoma

    Authors: , , , , , , , , , , , , , , , - Modern Pathology 2019 cited by 136

  22. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian Ganly, Marc A. Cohen, Nancy Y. Lee - JAMA Network Open 2023 cited by 47

  23. The mutational landscape of adenoid cystic carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yongxing Gong, Nikolaus Schultz, Seungwon Kim, Simion I. Chiosea, Jatin P. Shah, Chris Sander, William Lee, Timothy A. Chan - Nature Genetics 2013 cited by 463

  24. Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns

    Authors: , , , , , , , , , , , , , , , , , , , , , - Thyroid 2022 cited by 62